Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 14.1
edited by manuelmenendez
on 2025/01/27 23:58
on 2025/01/27 23:58
Change comment:
There is no comment for this version
To version 19.1
edited by manuelmenendez
on 2025/01/28 00:02
on 2025/01/28 00:02
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -2,9 +2,9 @@ 2 2 ((( 3 3 (% class="container" %) 4 4 ((( 5 -= //A new tridimensional diagnostic framework for CNS conditions// =5 += //A new tridimensional diagnostic framework for neurodegenerative diseases// = 6 6 7 -This project is focused on developing a novel nosological and diagnostic framework for neuro logicaldiseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies.7 +This project is focused on developing a novel nosological and diagnostic framework for neurodegenerative diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies. 8 8 We aim to create a structured, interpretable, and scalable diagnostic tool. 9 9 ))) 10 10 ))) ... ... @@ -17,14 +17,15 @@ 17 17 18 18 == **Overview** == 19 19 20 -The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDD s) are classified by focusing on:20 +The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDD) are classified by focusing on: 21 21 22 -* **Axis 1**: Etiology (genetic /sporadicand environmentalfactors).23 -* **Axis 2**: Molecular Markers (biomarkers and proteinopathies).22 +* **Axis 1**: Etiology (genetic or other causes of diseases). 23 +* **Axis 2**: Molecular Markers (biomarkers). 24 24 * **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system). 25 25 26 26 [[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]] 27 27 28 + 28 28 This methodology enables: 29 29 30 30 * Greater precision in diagnosis.